Lekshmon Ks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lekshmon Ks has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Alka Khadwal
Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 shared publicationsAmanjit Bal
Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 shared publicationsArihant Jain
Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 shared publicationsCharanpreet Singh
Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications- Deepesh Lad
Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications - Gaurav Prakash
Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 shared publications
Latest Publications
- 26 March 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (3) , e265666
Extramedullary manifestations of acute promyelocytic leukaemia at initial diagnosis: an autopsy analysis
This report documents a young female patient with microgranular variant acute promyelocytic leukaemia (APL) harbouring FLT3-ITD mutation who presented with fatigue, fever, gum bleeding and altered sensorium. Despite prompt initiation of all-trans retinoic acid and arsenic trioxide therapy, she developed worsening respiratory distress and neurological deterioration, succumbing within 70 hours of admission. Postmortem examination revealed extensive extramedullary leukaemic infiltration in the liver, heart, brain parenchyma and meninges, confirming widespread disease beyond the commonly recognised medullary involvement. This case highlights the diagnostic challenges in differentiating extramedullary APL from haemorrhagic complications and differentiation syndrome. Our literature review reveals that extramedullary involvement in APL at diagnosis is rare but clinically significant, with skeletal and central nervous system (CNS) being the most common sites. The optimal management strategies remain undefined, particularly for CNS-directed therapy. This case underscores the importance of considering extramedullary involvement in APL patients with atypical or rapidly progressive presentations.
- 26 March 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (3) , e265666
Extramedullary manifestations of acute promyelocytic leukaemia at initial diagnosis: an autopsy analysis
This report documents a young female patient with microgranular variant acute promyelocytic leukaemia (APL) harbouring FLT3-ITD mutation who presented with fatigue, fever, gum bleeding and altered sensorium. Despite prompt initiation of all-trans retinoic acid and arsenic trioxide therapy, she developed worsening respiratory distress and neurological deterioration, succumbing within 70 hours of admission. Postmortem examination revealed extensive extramedullary leukaemic infiltration in the liver, heart, brain parenchyma and meninges, confirming widespread disease beyond the commonly recognised medullary involvement. This case highlights the diagnostic challenges in differentiating extramedullary APL from haemorrhagic complications and differentiation syndrome. Our literature review reveals that extramedullary involvement in APL at diagnosis is rare but clinically significant, with skeletal and central nervous system (CNS) being the most common sites. The optimal management strategies remain undefined, particularly for CNS-directed therapy. This case underscores the importance of considering extramedullary involvement in APL patients with atypical or rapidly progressive presentations.
- Open Access
- 13 February 2025
- Published by Springer Nature in Blood Cancer Journal
- Vol. 15 (1) , 1
Correction: A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
- 13 February 2025
- Published by Springer Nature in Blood Cancer Journal
- Vol. 15 (1) , 1
Open AccessCorrection: A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
- Open Access
- 11 November 2024
- Published by Springer Nature in Blood Cancer Journal
- Vol. 14 (1) , 1-4
A simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma
- 11 November 2024
- Published by Springer Nature in Blood Cancer Journal
- Vol. 14 (1) , 1-4
Open AccessA simplified, two-factor clinical prognostic scoring system for patients with newly diagnosed Hodgkins Lymphoma